Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shen Zhao
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Xijing Hospital,
Air Force Medical University
ORCID:
0009-0007-9159-894X
Observed ORCID:
0009-0007-9159-894X
OpenAlex ID:
A5092127109
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
·
Cancer Research
·
78
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment
2026
·
Si-Wei Zhang
, Han Wang
, et al.
·
Cell
·
62
Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR+/HER2− breast cancer
2023
·
Jia Hu
, Hong Lv
, et al.
·
Journal of Thoracic Disease
·
20
PDF
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
2025
·
Lei Fan
, Wen-Juan Zhang
, et al.
·
Cancer Cell
·
9
Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma
2025
·
Jing Yan
, Rui An
, et al.
·
World Journal of Gastrointestinal Surgery
·
1
Data from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
·
1
Clinical and AI-derived Digital Pathology Features of Invasive Lobular and Ductal Carcinoma for Predicting 5-Year Recurrence or Metastasis
2026
·
Shuo-Wen Cao
, Xue-Ying Wang
, et al.
·
The Breast
Table S2 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S6 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S4 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S2 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S5 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S3 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S7 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S5 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S3 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S4 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2026
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S4 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
PDF
Table S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S5 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Figure S7 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
PDF
Table S4 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Table S3 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024
·
Yu-Wei Li
, Lei-Jie Dai
, et al.
Show more works
View as search
Works count:
32
Citation count:
170
H-index:
4
I10-index:
3
Year
Topic
Type